NIH-funded research R01 grant

Finding new ways to reduce heart disease in people with type 1 diabetes

Official title: Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes

Funded at Boston Children's Hospital · NIH-10991829 · Data updated 2026-11-12

This study is looking at how insulin can help keep cholesterol and inflammation in check in the liver for people with type 1 diabetes, with the goal of finding new treatments to lower their risk of heart disease.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 1, 2021
Project endNovember 30, 2025
Funding year2025
Award (this year)$624,822
NIH project number5R01HL161092-04
Project IDNIH-10991829 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with type 1 diabetes who are at risk for cardiovascular disease.

Less likely to help

Patients without type 1 diabetes or those who do not have cardiovascular disease risk factors may not benefit from this research.

What this research studies

This research investigates how insulin affects cholesterol and inflammation in the liver, particularly in individuals with type 1 diabetes who are at a higher risk for heart disease. The team aims to develop new drugs that can mimic the protective effects of insulin on the liver to help maintain healthy lipid levels and reduce inflammation. By studying a specific target in the liver, they hope to understand how restoring this target can prevent the progression of atherosclerosis, a condition that leads to cardiovascular disease. The research involves both laboratory studies and animal models to test their hypotheses.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly lower the risk of heart disease in patients with type 1 diabetes.

How similar studies have gone: Previous research has shown promising results in targeting metabolic pathways to reduce cardiovascular risks, suggesting that this approach may be effective.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Biddinger, Sudha B — Boston Children's Hospital
  • Study coordinator: Biddinger, Sudha B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.